OMA1 as a Theranostic Marker for Breast Cancer
- Detailed Technology Description
- This is a theranostic biomarker to predict breast cancer metastasis andhelp determine therapeutic regimens for patients.
- *Abstract
-
None
- *Licensing
- Arpi Siyahian, Ph.D.Technology Manager asiyahian@nutechventures.orgPhone: 818-599-2543
- Country/Region
- USA

For more information, please click Here